Skip to content

Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus

Soluble Dietary Fibres as Dietetic Aid to Reduce the Risks of Type 2 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01163006
Enrollment
60
Registered
2010-07-15
Start date
2010-03-31
Completion date
2011-03-31
Last updated
2018-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 Diabetes Mellitus

Brief summary

Controlling the glycemic impact of foodstuffs (by reducing the glycemic load of the diet by using soluble dietary fibres) may reduce the glycemic or insulinemic response. This may in turn result in a reduced inhibition of postprandial fat oxidation rate and a lower plasma triacylglycerol concentration A higher postprandial fat oxidation may result in less lipid accumulation in non-adipose tissue thereby improving insulin sensitivity and the metabolic profile in the longer term.

Interventions

OTHERPolydextrose and soluble gluco fibre

Polydextrose and soluble gluco fibre

Sponsors

Tate and Lyle Ingredients France
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight men and women

Exclusion criteria

* regular smokers, athletes, diabetes mellitus

Design outcomes

Primary

MeasureTime frame
fat oxidation

Secondary

MeasureTime frame
24h glucose pattern

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026